Zhi Yun Yu

Achieva Medical Shanghai Co. Ltd. manufactures medical devices. It provides coils, interventional accessories and in research products. The company was founded in March 2006 and is headquartered in Shanghai, China.

Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices.

Hangzhou Bota Biosciences Co., Ltd. is an industrial biotechnology company founded in 2019. The company is based in Hangzhou, China. Bota Biosciences aims to program biological systems for clean bio-manufacturing.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Achieva Medical Shanghai Co. Ltd. manufactures medical devices. It provides coils, interventional accessories and in research products. The company was founded in March 2006 and is headquartered in Shanghai, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Wuhan Tacro Technology Co., Ltd. is a company that manufactures medical devices. The company is based in Wuhan, China. The Chinese company was founded in 2011 by Lei Guo, Peng Xu, Jian Hui Zeng.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Wuhan Tacro Technology Co., Ltd. is a company that manufactures medical devices. The company is based in Wuhan, China. The Chinese company was founded in 2011 by Lei Guo, Peng Xu, Jian Hui Zeng.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Hangzhou Bota Biosciences Co., Ltd. is an industrial biotechnology company founded in 2019. The company is based in Hangzhou, China. Bota Biosciences aims to program biological systems for clean bio-manufacturing.

Hangzhou Bota Biosciences Co., Ltd. is an industrial biotechnology company founded in 2019. The company is based in Hangzhou, China. Bota Biosciences aims to program biological systems for clean bio-manufacturing.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

Wuhan Tacro Technology Co., Ltd. is a company that manufactures medical devices. The company is based in Wuhan, China. The Chinese company was founded in 2011 by Lei Guo, Peng Xu, Jian Hui Zeng.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Shenzhen Capital Group Co., Ltd. (SCGC) is an independent Chinese investment holding group which was established in 1999 and was formerly known as Shenzhen Venture Capital Co., Ltd. In 2002 the firm was restructured and renamed Shenzhen Capital Group Co., Ltd. Headquartered in Shenzhen, SCGC controls a number of investing subsidiaries and co-managed funds, providing venture capital investment and related value-added services and aiming to promote the development of the hi-tech industry in Shenzhen and greater China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

Matrix Partners (Beijing) Investment Management Co. Ltd. (Matrix Partners) is the private equity subsidiary of Matrix Management Corp was founded in 2008 by Zhang Ying, Shao Yi Bo and Su Tuong Sing. The firm headquartered in Beijing, China.